Giordanino, Chiara <br/><br/>
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Jan 2014 
 - 52-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0b013e328362dc99  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Glucose Metabolism Disorders--prevention & control<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Kaplan-Meier Estimate<br/>Liver Cirrhosis--prevention & control<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Polyethylene Glycols--adverse effects<br/>Proportional Hazards Models<br/>Prospective Studies<br/>RNA, Viral--blood<br/>Recombinant Proteins--adverse effects<br/>Recurrence<br/>Ribavirin--adverse effects<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load